Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorCognitive behavioral therapy for substance use disordersBipolar disorder and alcohol use disorder: a reviewLow dose naltrexone for induction of remission in Crohn's diseaseAnticonvulsants for alcohol dependenceLow dose naltrexone for induction of remission in Crohn's diseaseAcamprosate for alcohol dependenceOpioid antagonists for alcohol dependenceInvolvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosateNalmefene: a new approach to the treatment of alcohol dependenceAcamprosate: a prototypic neuromodulator in the treatment of alcohol dependenceA blocker of N- and T-type voltage-gated calcium channels attenuates ethanol-induced intoxication, place preference, self-administration, and reinstatementIntermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependenceAn evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyGlutamatergic substrates of drug addiction and alcoholismMindfulness meditation for substance use disorders: a systematic reviewIn the Clinic. Alcohol UsePrecision in Addiction Care: Does It Make a Difference?Guidelines for the Reporting of Treatment Trials for Alcohol Use DisordersCognitive Neuroscience Approaches to Understanding Behavior Change in Alcohol Use Disorder TreatmentsAlcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinenceGlutamatergic targets for new alcohol medicationsThe development of acamprosate as a treatment against alcohol relapse2012 Update in addiction medicine for the generalistTreatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed ModelThe relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humansTargeting glutamate uptake to treat alcohol use disordersCare for hospitalized patients with unhealthy alcohol use: a narrative reviewTargeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disordersRecommendations for the Design and Analysis of Treatment Trials for Alcohol Use DisordersImproving clinical outcomes for naltrexone as a management of problem alcohol useProteomic approaches and identification of novel therapeutic targets for alcoholismCommon and distinct neural targets of treatment: changing brain function in substance addictionThe Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.Distribution-free Inference of Zero-inated Binomial Data for Longitudinal StudiesThe clinical pharmacology of acamprosate.Medications for unhealthy alcohol use: across the spectrum.Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connectAcamprosate: A Review of Its Use in Alcohol DependenceTargeted opioid receptor antagonists in the treatment of alcohol use disorders
P2860
Q22241964-4912E5E3-0B20-42E2-B019-1D8FABF03AA5Q22251196-BC2F29F3-B149-4D15-AFDD-D0B8A81CD409Q22252584-947E2024-0F80-48C2-88A0-8A846A394546Q24200319-A4854D81-D0D5-4EC9-B9D7-BD284D1E2F19Q24200396-14105AB9-7FDE-492F-9DF1-7BC5E16BCE0CQ24201218-E55C99BA-4FB0-40A3-A6E6-B76A3015D667Q24235594-76540672-907E-4035-B943-546BE1C15EC5Q24235797-0D7D3357-7F81-479A-9CEB-D4DE071ED5B9Q24336813-04A4C30E-0695-43C1-89BA-88A66B21A4DAQ24564708-FA714201-5F33-4BEB-9855-BFDA197A1D2CQ24595863-E4597021-ECDA-4CDD-9D4D-109B23527818Q24613295-258BEA58-0830-4CB8-A0F5-4FDAC2C83EEFQ24645054-C5FFEB54-20A8-4C88-8AD8-5656733FAEDFQ24645469-C2FADACB-FD6F-48A1-ADC0-49CE9CB5A5C0Q24648924-E06566CF-5737-43ED-935D-1EC8B0E592CDQ24651476-D67E795E-5373-4968-A1DF-113DBDB03304Q26770054-4887B7F1-4156-43EF-B2C4-FACC8A6E2239Q26775801-BC93F2B3-15E4-41A6-8B51-42201057710FQ26779440-AED6FE13-059B-4FFF-8E68-ACE06534549AQ26799811-C64474CE-5ACB-45E5-9D34-F18AFA6A3437Q26801196-1E684B9D-605D-46B7-8ED4-EADE4AF066FDQ26824012-1AC3F9AF-3B98-4ED5-89D0-DD0226259EDCQ26862199-ED553BF8-374F-454B-A256-2A0C385A375CQ26864774-6799ABC0-00F8-42AA-9133-6826EC648913Q26866733-56ADD994-2C5C-4A3D-9EDE-7D8AD75DC317Q26992207-FE4A3573-D819-43A4-B9CB-CC135F2A8573Q27002488-B2CD43E9-5316-4CD3-9FA9-5A2A749D2E0EQ27004298-AEEB2D49-3E31-4DB6-ABE9-5C2DF842F9E8Q27008813-E5464C73-705A-4D3E-9B6B-ADF94D1CEAA6Q27013929-C9FB5BB7-C694-4F1E-9255-0C64703C429AQ27021406-7F2AEC99-2C1E-4E5C-9B9F-F365730A0E22Q27023085-A32A4CDF-512A-43EC-8C92-AFC3A4B3DBD1Q27027961-9F9387C9-4E8A-4137-A0A0-ED05AB054B4DQ27310644-F49D3C56-92F6-4B60-BF75-5A4F943EB6FCQ27311565-0A2F8E12-E2CA-430B-A59F-C9E1FA5CA2EFQ27687874-365FAD2E-CBDC-4E9A-9F5C-ED45E1E19BFFQ27690692-D0CFEB9B-ACAE-48AC-AD10-F8A2C6EA5134Q27693265-F20A159F-EE16-4058-8028-38FCBD4ACCDAQ28263633-1E3E98BB-B89B-4525-8FAE-FF26FCF69AF9Q28295125-2991BF08-3684-4225-8336-701821E1E7DB
P2860
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Combined pharmacotherapies and ...... a randomized controlled trial.
@en
type
label
Combined pharmacotherapies and ...... a randomized controlled trial.
@en
prefLabel
Combined pharmacotherapies and ...... a randomized controlled trial.
@en
P2093
P50
P356
P1476
Combined pharmacotherapies and ...... a randomized controlled trial
@en
P2093
Allen Zweben
Bankole A Johnson
Barbara J Mason
COMBINE Study Research Group
Carrie L Randall
David R Gastfriend
Helen M Pettinati
James D Hosking
Joseph S LoCastro
Lauren D Williams
P304
P356
10.1001/JAMA.295.17.2003
P407
P577
2006-05-01T00:00:00Z